Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Nielepkowicz, J. Marczak, A. Pekala-Wojciechowska, A. Baranowska, P. Gorski, W. Piotrowski, A. Antczak (Lodz, Poland). Exhaled bimarkers in exacerbation of COPD. Eur Respir J 2007; 30: Suppl. 51, 510

Member's Comments

No comment yet.

Related content which might interest you: Exhaled NO (FeNO) levels in patients with exacerbation of COPD and/or bronchiectasis Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Exhaled breath condensate for evaluation of inflammation in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006 The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 Exhaled NO and bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 280s Year: 2005 Exhaled breath condensates and COPD Source: Eur Respir J 2009; 33: 1238 Year: 2009 Exhaled breath temperature in COPD patients Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Exhaled breath condensate pH and exhaled nitric oxide in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 18s Year: 2003 Exhaled breath temperature increases at COPD exacerbation and correlates with sputum neutrophilia Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Assessment of exhaled breath condensate pH in asthma and COPD patients with exacerbation Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 Exhaled breath analyses in bronchial thermoplasty for severe asthma Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine Year: 2021 Exhaled breath condensate nitrate/nitrite in asthma, COPD and healthy controls Source: Eur Respir J 2006; 28: Suppl. 50, 283s Year: 2006 Exhaled breath condensate eicosanoids as markers of asthma severity Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Exhaled nitric oxide as a predictor of exacerbations of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004 Nitric oxide in exhaled breath is poorly correlated to eosinophilic bronchitis in prednisone-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Investigation of nitric oxide level in the exhaled breath condensate in asthma and COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005 Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Prediction of asthma exacerbations in children by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008 Exhaled NO but not eosinophilic inflammation is reduced by inhaled corticosteroid treatment in COPD Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008